Journal of Urologic Oncology

The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer: Jae Young Joung, Sung Han Kim; Korean J Urol Oncol. 2022;20(1):1-11. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.1
Cited By 1; Full text PubReader ePub PDF

New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer: Jaewoon Jeong, Jae Baek Ha, In Ho Chang; Korean J Urol Oncol. 2022;20(1):12-24. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.12; Full text PubReader ePub PDF

De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors: Sung Han Kim, Eun Young Park, Hyung-Ho Lee, Jinsoo Chung, Ho Kyung Seo; Korean J Urol Oncol. 2022;20(1):25-33. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.25; Full text PubReader ePub PDF

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor With Upper Urinary Tract Carcinoma Who Underwent Radical Nephroureterectomy and Adjuvant Chemotherapy: Jee Hwan Yoon, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku, Ji Hyeong Yu, Hyeong Dong Yuk; Korean J Urol Oncol. 2022;20(1):34-42. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.34; Full text PubReader ePub PDF

The Incidence of Prostate-Specific Antigen Test in a Country With a Limited Social Perception of Prostate Cancer 2006-2016: Disparities Manifested by Residential Area: Young Hwii Ko, Byung Hoon Kim; Korean J Urol Oncol. 2022;20(1):43-51. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.43
Cited By 2; Full text PubReader ePub PDF

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Korean J Urol Oncol. 2022;20(1):52-58. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.52
Correction in: 2023;21(3):277; Full text PubReader ePub PDF

Inflammatory Myofibroblastic Tumor of the Urinary Bladder in a Young Patient With Gross Hematuria: A Case Report: Han Kyu Chae, Wook Nam, Sung Jin Kim, Byeong-Joo Noh, Jong Yeon Park; Korean J Urol Oncol. 2022;20(1):59-62. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.59; Full text PubReader ePub PDF

Solitary Brain Metastasis Detected 1 Year After Robot-Assisted Laparoscopic Radical Nephrectomy: A Case Report: Ji Kang Yun, Woong Bin Kim, Si Hyun Kim, Ahrim Moon, Sang Wook Lee; Korean J Urol Oncol. 2022;20(1):63-68. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.63; Full text PubReader ePub PDF

Patient-Specific Tumor Microenvironment Models: Jung Woo Lee, Jia Kim, Youngjae Shin, Byung Hoon Chi, Jung Hoon Kim, In Ho Chang, Se Young Choi; Korean J Urol Oncol. 2022;20(1):69-69. Published online February 24, 2022; DOI: https://doi.org/10.22465/kjuo.2022.20.1.69
Corrects: 2021;19(4):197; Full text PubReader ePub PDF

5,374	Complex Epidemiology of Prostate Cancer in Asian Countries
3,666	Current Update on Prostate Cancer Immunotherapy
3,318	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
3,255	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
3,126	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023

Cited By 10	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 9	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 3	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
Cited By 2	A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening

Previous issues